Calmare Therapeutics Incorporated (OTCQX: CTTC) a full service provider of distribution, patent and technology transfer, selling and licensing services, is focused on the needs of its customers and transforming those needs into commercially viable product or technology solutions provided by its clients. CTI is a global leader in identifying, developing, and commercializing innovative technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTI maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. SNNLive spoke with Conrad Mir, President & CEO of Calmare Therapeutics Incorporated at the LD Micro "Main Event" 2014 in Bel Air, CA.
Mr. Mir begins with an overview of the company, “Calmare is a pain device company, that is our flagship product and it has a very unique way of treating pain and we are an FDA cleared product.”
He explains the technology behind the product, “We treat pain by not treating pain at all. We have an algorithm in a machine and the machine is a glorified computer and the computer tries to flood the brain with no pain signals versus the pain signals that are coming from the source to the patient’s brain.”
He concludes by stating where the product can be found, “We have over 50 different centers in the United States, the majority of the centers are on the east coast but we also have centers Korea, we have centers in Italy, we have centers in the Middle East.” For more information, check out their website: www.CalmareTherapeutics.com
© 2017 Stock News Now
Supported by Superior Web Solutions